Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alpha Szenszor Inc.

www.alphaszenszor.com

Latest From Zhejiang Hisun Pharmaceutical Co. Ltd.

Celltrion Gets Go-Ahead For Remsima Trials In China, Mulls JV

Celltrion has received approval to begin clinical trials of its biosimilar infliximab in China and also filed IND applications for other biosimilar products with the CFDA, accelerating plans to enter the world’s second biggest pharma market as it propels efforts for global leadership in the biosimilar space.

Commercial Companies

Sanofi's Biosimilars Deal With JHL Confirms Growing Trend In China

Sanofi is joining the biosimilars trend to tap into China through a local partnership with Taiwan's JHL Biotech, initially focusing on rituximab, a biosimilar product that has great market potential but strong competition in development by domestic peers.

China Biosimilars

Can An Elephant Crack China’s Bamboo Ceiling For Generics?

Among the many challenges facing foreign generics firms operating in China, dealing with ever-tightening policies and regulations is probably the toughest, and has already forced several multinationals to quit the market. But one Indian joint venture is looking to effectively exploit targeted niche opportunities.

China Business Strategies

Fujifilm Promises A Shake-Up Of Regenerative Medicines Market

Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.

Regenerative Medicine Regenerative Medicine
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Biosensors
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Alpha Szenszor Inc.
  • Senior Management
  • Steve Lerner, CEO
  • Contact Info
  • Alpha Szenszor Inc.
    Cambridge, MA
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register